MedPath

Select-OB Plus DHA

Select-OB+DHA

Approved
Approval ID

cb5c567a-8733-4004-832e-de8132b8da9e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jul 24, 2023

Manufacturers
FDA

Exeltis USA, Inc.

DUNS: 071170534

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

.BETA.-CAROTENE, VITAMIN A ACETATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, Thiamine Mononitrate, Riboflavin, NIACINAMIDE, Pyridoxine Hydrochloride, Folic Acid, LEVOMEFOLATE CALCIUM, Cobalamin, Iron, MAGNESIUM OXIDE, ZINC OXIDE, and DOCONEXANT

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code0642-0075
Product Classification
G
Generic Name
.BETA.-CAROTENE, VITAMIN A ACETATE, ASCORBIC ACID, CHOLECALCIFEROL, .ALPHA.-TOCOPHEROL ACETATE, DL-, Thiamine Mononitrate, Riboflavin, NIACINAMIDE, Pyridoxine Hydrochloride, Folic Acid, LEVOMEFOLATE CALCIUM, Cobalamin, Iron, MAGNESIUM OXIDE, ZINC OXIDE, and DOCONEXANT
Product Specifications
Effective DateJuly 24, 2023
FDA Product Classification

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 1/13/2021

PRINCIPAL DISPLAY PANEL - Kit Carton

0642-0075-30

Select-OB+DHA ®

Prenatal Supplement with DHA

Berry flavored BLUE Select-OB ® Caplet
can be chewed or swallowed

DHA Softgel Capsule

from natural source DHA

Smaller DHA Softgel

DOES NOT CONTAIN
FISH OIL

R X

Unit Dose Pack

30 Caplets and 30 Softgel Capsules

U.S. Patented

PRINCIPAL DISPLAY PANEL - Kit Carton

BOXED WARNING SECTION

LOINC: 34066-1Updated: 1/13/2021

WARNING

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. Keep this product out of reach of children. In case of accidental overdose, call a doctor or a Poison Control Center immediately.

INDICATIONS & USAGE SECTION

LOINC: 34067-9Updated: 1/13/2023

INDICATIONS AND USAGE

Select-OB+DHA ® is indicated to provide vitamin, mineral, and omega-3 fatty acid supplementation prior to conception, throughout pregnancy, and during the postnatal period for the lactating and non-lactating mother.*

Select-OB+DHA ® does not contain fish, fish oils, fish proteins or fish byproducts.

CONTRAINDICATIONS SECTION

LOINC: 34070-3Updated: 1/13/2021

CONTRAINDICATIONS

Select-OB+DHA ® is contraindicated in patients with hypersensitivity to any of its components or color additives. Folic acid is contraindicated in patients with untreated and uncomplicated pernicious anemia, and in those with anaphylactic sensitivity to folic acid. Iron therapy is contraindicated in patients with hemochromatosis and patients with iron storage disease or the potential for iron storage disease due to chronic hemolytic anemia (e.g., inherited anomalies of hemoglobin structure or synthesis and/or red cell enzyme deficiencies, etc.), pyridoxine responsive anemia, or cirrhosis of the liver.

Cyanocobalamin is contraindicated in patients with sensitivity to cobalt or to cyanocobalamin (vitaminB12).

ADVERSE REACTIONS SECTION

LOINC: 34084-4Updated: 1/13/2021

ADVERSE REACTIONS

Adverse reactions have been reported with specific vitamins and minerals, but generally at doses substantially higher than those in Select-OB+DHA ®.

WARNINGS SECTION

LOINC: 34071-1Updated: 1/13/2021

WARNINGS/PRECAUTIONS

Select-OB+DHA ® should be used with caution in patients with known sensitivity or allergy to soy.

Vitamin D supplementation should be used with caution in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones. High doses of vitamin D can lead to elevated levels of calcium that reside in the blood and soft tissues. Bone pain, high blood pressure, formation of kidney stones, renal failure, and increased rick of heart disease can occur. Prolonged use of iron slats may produce iron storage disease.

Folic acid, especially in doses above 0.1 mg daily, may obscure pernicious anemia, in that hematologic remission may occur while neurological manifestations remain progressive. The use of folic acid doses above 1 mg daily may precipitate or exacerbate the neurological damage of vitamin B12 deficiency. Consumption of more than 3 grams of omega-3 fatty acids per day from all sources may lead to excessive bleeding.

Supplemental intake of omega-3 fatty acids such as DHA exceeding 2 grams per day is not recommended.

Avoid overdosage. Keep out of the reach of children.

Drug Interactions

High doses of folic acid may result in decreased serum levels of the anticonvulsant drugs.

Vitamin D supplementation should not be given with large amounts of calcium in those with hypercalcemia or conditions that may lead to hypercalcemia such as hyperparathyroidism and those who form calcium-containing kidney stones.

Zinc can inhibit the absorption of certain antibiotics; take at least 2 hours apart to minimize interactions. Consult appropriate references for additional specific vitamin-drug interactions.

Information for Patients

Patients should be counseled to disclose all medical conditions, including use of all medications, vitamins and supplements, pregnancy, and breast-feeding.

Pediatric Use

Not for pediatric use.

DOSAGE & ADMINISTRATION SECTION

LOINC: 34068-7Updated: 1/13/2021

DOSAGE AND ADMINISTRATION

Before, during and after pregnancy, chew or swallow one blue Select OB ® caplet and swallow one DHA softgel capsule daily, or as directed by a physician.

HOW SUPPLIED SECTION

LOINC: 34069-5Updated: 1/13/2021

HOW SUPPLIED

Select-OB+DHA ® is available as a light blue caplet debossed EV0077 and one amber-colored DHA softgel capsule. Available in Box of Unit-Dose pack of 30 (5 child resistant blister cards of 6 SELECT-OB ® caplets and 6 DHA softgel capsules each) (0642-0075-30) and as professional samples (0642-0075-03).

Store at room temperature, approximately 15°-30°C (59°-86°F), avoid excessive heat and moisture.

SPL UNCLASSIFIED SECTION

LOINC: 42229-5Updated: 1/13/2021

*These statements have not been evaluated by the Food and Drug Administration.This product is not intended to diagnose, treat, cure, or prevent any disease.

Rx

Distributed by:


** Exeltis USA, Inc.**


** Florham Park, NJ 07932**

1-877-324-9349

www.exeltisusa.com

©2023 Exeltis USA, Inc. All rights reserved.

U.S. Patent No. 7,560,123; 8,101,587; 8,197,855; and 8,609,629

Select-OB+DHA ® is a trademark of Exeltis Healthcare, S.L.

Rev. January 2023 0753001-02

DESCRIPTION SECTION

LOINC: 34089-3Updated: 1/9/2023

COMPOSITION

Each SELECT-OB ® caplet contains:

Vitamin A (as retinyl acetate & beta carotene)

510 mcg RAE (1700 IU)

Vitamin C (as ascorbic acid)

60 mg

Vitamin D (as cholecalciferol)

10 mcg (400 IU)

Vitamin E (as dl-alpha tocopheryl acetate)

13.5 mg (30 IU)

Thiamin (Vitamin B1 as thiamine mononitrate)

1.6 mg

Riboflavin (Vitamin B2)

1.8 mg

Niacin (as niacinamide)

15 mg NE

Vitamin B6 (as pyridoxine hydrochloride)

2.5 mg

Folate (as folic acid)

1700 mcg DFE

Vitamin B12 (as cyanocobalamin)

5 mcg

Iron (as polysaccharide iron complex)

29 mg

Magnesium (as magnesium oxide)

25 mg

Zinc (as zinc oxide)

15 mg

Each softgel capsule contains:

Docosahexaenoic acid (DHA)

(from natural algal oil)

250 mg

Other Ingredients in Select-OB ® caplet: Fructose, Stearic Acid, Mono and Diglycerides, Croscarmellose Sodium, Mixed Berry Flavor WONF, Gelatin (Porcine), Silicon Dioxide, Citric Acid, Magnesium Stearate, Modified Food Starch, Hydroxypropylmethyl Cellulose, Malic Acid, Sucrose, Corn Starch, Dicalcium Phosphate, Sodium Ascorbate, Medium Chain Triglycerides, Sorbic Acid, Tocopherol Concentrate, Sodium Benzoate, dl-Alpha-Tocopherol, Butylated Hydroxytoluene (BHT), Tricalcium Phosphate. Coating: Hydroxypropylmethyl Cellulose, Titanium Dioxide, Polydextrose, Hydroxypropyl Cellulose, Triacetin, Polyethylene Glycol, FD&C Blue #1 / Aluminum Lake, FD&C Blue #2 / Aluminum Lake.Contains: Soy

Other Ingredients in DHA softgel capsule: Gelatin, Glycerin USP, Water.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Select-OB Plus DHA - FDA Drug Approval Details